The opening keynote panel on day 1 of SCOPE (Summit for Clinical Operations Executives) Summit 2025 focused on the main stakeholder in clinical trials—patients. Titled, “What Do Real Patients Actually Talk About?” the interactive panel discussed the importance of accurately representing patient voices, particularly those from underrepresented communities, in clinical research.
The discussion was moderated by T. Hephner, CRO, Inspire. He was joined by Emily McCormack, social media director, New York Blood Center; Quynh Tran, MPH, director of patient activation, Cystic Fibrosis Foundation; Fabian Sandoval, PhD, president & CEO, Emerson Clinical Research Institute; and Darious Davis, senior director of business development, CenExel.
